Gamma vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds

被引:61
作者
Kushner, SA
Dewey, SL
Kornetsky, C
机构
[1] BOSTON UNIV, SCH MED, DEPT PHARMACOL, BOSTON, MA 02118 USA
[2] BOSTON UNIV, SCH MED, DEPT PSYCHIAT, BOSTON, MA 02118 USA
[3] BROOKHAVEN NATL LAB, ASSOCIATED UNIVS INC, DEPT CHEM, UPTON, NY 11973 USA
关键词
intracranial self stimulation (ICSS); dopamine; rat; GABA transaminase inhibitor; vigabatrin;
D O I
10.1007/s002130050418
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gamma-vinyl GABA (GVG, also referred to as vigabatrin), an irreversible inhibitor of GABA transaminase (GABA-T), raises levels of GABA in nerve terminals, inhibits striatal dopamine release, and attenuates cocaine-induced increases in extracellular dopamine in the striatum and nucleus accumbens. In order to determine the action of GVG on dopamine-mediated reward, we examined its effects on the threshold for rewarding brain stimulation in male F-344 rats. GVG dose-dependently raised brain stimulation reward (BSR) thresholds at doses of 200, 300, and 400 mg/kg without significant effects on motor performance as measured by response latencies. In order to determine if GVG had similar modulatory effects on cocaine-induced lowering of BSR thresholds, the effective doses of GVG were co-administered with 2.5 and 5.0 mg/kg cocaine, doses that significantly lower BSR thresholds. The 400 mg/kg dose of GVG significantly blocked the lowering of thresholds seen at each dose of cocaine. Cocaine in combination with 200 or 300 mg/kg GVG, doses of GVG that significantly raise BSR thresholds, resulted in thresholds not significantly different from those obtained with cocaine alone. These data demonstrate that, at the doses tested, GVG is more effective at modulating basal reward thresholds than at modulating thresholds lowered by cocaine, implying that as dopaminergic activity increases, GABAergic activity must also increase in order to exert its inhibitory influence on dopaminergic activity.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 24 条
[1]  
CHURCHILL L, 1991, ADV EXP MED BIOL, V295, P101
[2]   AUTORADIOGRAPHIC LOCALIZATION OF GAMMA-AMINOBUTYRIC ACIDA RECEPTORS WITHIN THE VENTRAL TEGMENTAL AREA [J].
CHURCHILL, L ;
DILTS, RP ;
KALIVAS, PW .
NEUROCHEMICAL RESEARCH, 1992, 17 (01) :101-106
[3]  
DEWEY SL, 1997, IN PRESS SYNAPSE
[4]   MORPHINE LOWERING OF SELF-STIMULATION THRESHOLDS - LACK OF TOLERANCE WITH LONG-TERM ADMINISTRATION [J].
ESPOSITO, R ;
KORNETSKY, C .
SCIENCE, 1977, 195 (4274) :189-191
[5]   CHRONIC ELEVATION OF BRAIN GABA BY GAMMA-VINYL GABA TREATMENT DOES NOT ALTER THE SENSITIVITY OF GABAERGIC OR DOPAMINERGIC RECEPTORS IN RAT CNS [J].
GARDNER, CR ;
MALLORGA, P ;
KLEIN, J ;
HUOTOLIVIER, S ;
PALFREYMAN, MG .
PSYCHOPHARMACOLOGY, 1983, 79 (2-3) :130-136
[6]   SPECIFICITY IN THE PROJECTION PATTERNS OF ACCUMBAL CORE AND SHELL IN THE RAT [J].
HEIMER, L ;
ZAHM, DS ;
CHURCHILL, L ;
KALIVAS, PW ;
WOHLTMANN, C .
NEUROSCIENCE, 1991, 41 (01) :89-125
[7]   BLOCKADE OF METHAMPHETAMINE-INDUCED DEPRESSION OF TYROSINE-HYDROXYLASE BY GABA TRANSAMINASE INHIBITORS [J].
HOTCHKISS, A ;
GIBB, JW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 66 (2-3) :201-205
[8]   GAMMA-VINYL GABA (4-AMINO-HEX-5-ENOIC ACID), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA-T - EFFECTS ON BRAIN GABA METABOLISM IN MICE [J].
JUNG, MJ ;
LIPPERT, B ;
METCALF, BW ;
BOHLEN, P ;
SCHECHTER, PJ .
JOURNAL OF NEUROCHEMISTRY, 1977, 29 (05) :797-802
[9]  
KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858
[10]   GABA AND ENKEPHALIN PROJECTION FROM THE NUCLEUS-ACCUMBENS AND VENTRAL PALLIDUM TO THE VENTRAL TEGMENTAL AREA [J].
KALIVAS, PW ;
CHURCHILL, L ;
KLITENICK, MA .
NEUROSCIENCE, 1993, 57 (04) :1047-1060